Tocilizumab offers hope in GCA

Tocilizumab has been shown to be effective in inducing and maintaining remission of giant cell arteritis in a small randomised trial.

Around 30 patients were randomised in a 2:1 ratio to receive tocilizumab plus glucocorticoid therapy or placebo plus glucocorticoids.

The glucocorticoids were started at 1mg/kg/d and then gradually tapered down over the course of the trial.